Everett Harris & CO Becton Dickinson & CO Transaction History

Everett Harris & CO

$8 Billion
Q3 2024

A detailed history of Everett Harris & CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Everett Harris & CO holds 567,362 shares of BDX stock, worth $130 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares

567,362

Previous 568,767 0.25%

Holding current value

$130 Million

Previous $133 Million 2.91%

% of portfolio

1.71%

Previous 1.71%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$221.47 - $242.41 $311,165 - $340,586	-1,405 Reduced 0.25%	567,362 $137 Million
Q2 2024 Aug 01, 2024	SELL	$225.07 - $246.17 $471,296 - $515,479	-2,094 Reduced 0.37%	568,767 $133 Million
Q1 2024 Apr 19, 2024	SELL	$233.45 - $247.73 $555,144 - $589,101	-2,378 Reduced 0.41%	570,861 $141 Million
Q4 2023 Jan 18, 2024	SELL	$232.24 - $267.23 $237,581 - $273,376	-1,023 Reduced 0.18%	573,239 $140 Million
Q3 2023 Oct 23, 2023	SELL	$254.9 - $283.59 $1.51 Million - $1.67 Million	-5,906 Reduced 1.02%	574,262 $148 Million
Q2 2023 Jul 26, 2023	BUY	$238.39 - $265.32 $24.5 Million - $27.3 Million	102,890 Added 21.56%	580,168 $153 Million
Q1 2023 Apr 24, 2023	BUY	$229.71 - $259.35 $158,040 - $178,432	688 Added 0.14%	477,278 $118 Million
Q4 2022 Jan 20, 2023	BUY	$218.29 - $256.91 $166,555 - $196,022	763 Added 0.16%	476,590 $0
Q3 2022 Oct 21, 2022	SELL	$51.03 - $264.23 $465,240 - $2.41 Million	-9,117 Reduced 1.88%	475,827 $106 Million
Q2 2022 Jul 22, 2022	SELL	$234.74 - $275.42 $247,885 - $290,843	-1,056 Reduced 0.22%	484,944 $120 Million
Q1 2022 Apr 22, 2022	BUY	$243.64 - $270.48 $124,500 - $138,215	511 Added 0.11%	486,000 $129 Million
Q4 2021 Feb 02, 2022	BUY	$230.08 - $250.94 $532,405 - $580,675	2,314 Added 0.48%	485,489 $122 Million
Q3 2021 Nov 03, 2021	SELL	$232.72 - $256.47 $279,729 - $308,276	-1,202 Reduced 0.25%	483,175 $119 Million
Q2 2021 Jul 29, 2021	SELL	$232.65 - $254.58 $94,455 - $103,359	-406 Reduced 0.08%	484,377 $118 Million
Q1 2021 May 13, 2021	SELL	$232.09 - $256.88 $647,066 - $716,181	-2,788 Reduced 0.57%	484,783 $118 Million
Q4 2020 Feb 04, 2021	BUY	$221.92 - $245.94 $1.02 Million - $1.13 Million	4,590 Added 0.95%	487,571 $122 Million
Q3 2020 Nov 03, 2020	BUY	$215.77 - $276.76 $3.08 Million - $3.95 Million	14,269 Added 3.04%	482,981 $112 Million
Q2 2020 Jul 29, 2020	BUY	$219.9 - $263.41 $10.7 Million - $12.8 Million	48,572 Added 11.56%	468,712 $112 Million
Q1 2020 Apr 29, 2020	BUY	$195.69 - $279.01 $5.66 Million - $8.07 Million	28,934 Added 7.4%	420,140 $96.5 Million
Q4 2019 Jan 27, 2020	SELL	$236.45 - $266.82 $3,546 - $4,002	-15 Reduced -0.0%	391,206 $106 Million
Q3 2019 Nov 06, 2019	SELL	$230.58 - $256.08 $141,114 - $156,720	-612 Reduced 0.16%	391,221 $99 Million
Q2 2019 Aug 13, 2019	BUY	$217.4 - $246.08 $81,525 - $92,280	375 Added 0.1%	391,833 $98.7 Million
Q1 2019 May 13, 2019	SELL	$206.05 - $248.17 $1.31 Million - $1.58 Million	-6,370 Reduced 1.6%	391,458 $97.8 Million
Q4 2018 Feb 13, 2019	SELL	$204.73 - $257.93 $708,365 - $892,437	-3,460 Reduced 0.86%	397,828 $89.6 Million
Q3 2018 Nov 14, 2018	SELL	$233.07 - $256.0 $533,264 - $585,728	-2,288 Reduced 0.57%	401,288 $105 Million
Q2 2018 Jul 27, 2018	SELL	$208.1 - $233.85 $760,189 - $854,254	-3,653 Reduced 0.9%	403,576 $96.7 Million
Q1 2018 Apr 20, 2018	BUY	$205.46 - $240.27 $1.18 Million - $1.38 Million	5,760 Added 1.43%	407,229 $88.2 Million
Q4 2017 Feb 01, 2018	SELL	$189.0 - $222.64 $81,648 - $96,180	-432 Reduced 0.11%	401,469 $85.9 Million
Q3 2017 Oct 11, 2017	BUY	$186.89 - $198.9 $75.1 Million - $79.9 Million	401,901	401,901 $78.8 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.

Account

Everett Harris & CO Becton Dickinson & CO Transaction History